Multi-organ CT/X-ray analysis suite, including coronary calcium scoring; flagship platform now marketed as Nanox.ARC.
At least 8 confirmed FDA 510(k) clearances across modules, including coronary calcium scoring; Nanox.ARC received a further general FDA clearance in 2026.
Investor press release confirming the 8th FDA 510(k).
Not found in this research pass — verify before publishing.
Not quantified in the sources gathered so far.
Rebranding from Zebra Medical Vision to Nanox.AI must be reflected consistently — do not reuse the old name.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.